diindolylmethane

DRUG3 trials

Sponsors

National Cancer Institute (NCI), University of Arizona

Conditions

Adenocarcinoma of the ProstateHealthy, no Evidence of DiseaseProstate CancerStage I Prostate CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage II Prostate Cancer

Phase 1

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

CompletedNCT00450229

National Cancer Institute (NCI)Adenocarcinoma of the Prostate, Prostate Cancer, Stage II Prostate Cancer +1

Start: 2007-02-28End: 2010-02-28Updated: 2015-12-04

Diindolylmethane in Preventing Cancer in Healthy Volunteers

CompletedNCT00784394

National Cancer Institute (NCI)Healthy, no Evidence of Disease

Start: 2004-04-30End: 2009-10-31Updated: 2016-12-29

Unknown Phase

Diindolylmethane in Treating Patients With Breast Cancer

CompletedNCT01391689

University of ArizonaStage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer +1

Start: 2011-02-28End: 2016-07-31Updated: 2017-11-06

Related Papers

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

2017-05-3042 citations